477 related articles for article (PubMed ID: 25077810)
21. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine.
Nostro MC; Keller G
Semin Cell Dev Biol; 2012 Aug; 23(6):701-10. PubMed ID: 22750147
[TBL] [Abstract][Full Text] [Related]
22. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
Kempf H; Andree B; Zweigerdt R
Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
[TBL] [Abstract][Full Text] [Related]
23. A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production.
Sundberg M; Hyysalo A; Skottman H; Shin S; Vemuri M; Suuronen R; Narkilahti S
Regen Med; 2011 Jul; 6(4):449-60. PubMed ID: 21749203
[TBL] [Abstract][Full Text] [Related]
24. Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.
Hongisto H; Ilmarinen T; Vattulainen M; Mikhailova A; Skottman H
Stem Cell Res Ther; 2017 Dec; 8(1):291. PubMed ID: 29284513
[TBL] [Abstract][Full Text] [Related]
25. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.
Vaajasaari H; Ilmarinen T; Juuti-Uusitalo K; Rajala K; Onnela N; Narkilahti S; Suuronen R; Hyttinen J; Uusitalo H; Skottman H
Mol Vis; 2011 Feb; 17():558-75. PubMed ID: 21364903
[TBL] [Abstract][Full Text] [Related]
26. Scalable expansion of human pluripotent stem cells in suspension culture.
Zweigerdt R; Olmer R; Singh H; Haverich A; Martin U
Nat Protoc; 2011 May; 6(5):689-700. PubMed ID: 21527925
[TBL] [Abstract][Full Text] [Related]
27. Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.
Chen Y; Tristan CA; Mallanna SK; Ormanoglu P; Titus S; Simeonov A; Singeç I
Methods Mol Biol; 2019; 1919():59-72. PubMed ID: 30656621
[TBL] [Abstract][Full Text] [Related]
28. Single cell heterogeneity in human pluripotent stem cells.
Yang S; Cho Y; Jang J
BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
[TBL] [Abstract][Full Text] [Related]
29. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture.
Hughes C; Radan L; Chang WY; Stanford WL; Betts DH; Postovit LM; Lajoie GA
Mol Cell Proteomics; 2012 Dec; 11(12):1924-36. PubMed ID: 23023296
[TBL] [Abstract][Full Text] [Related]
31. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
32. Efficient passage of human pluripotent stem cells on spider silk matrices under xeno-free conditions.
Wu S; Johansson J; Hovatta O; Rising A
Cell Mol Life Sci; 2016 Apr; 73(7):1479-88. PubMed ID: 26427704
[TBL] [Abstract][Full Text] [Related]
33. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
34. Derivation of neural crest cells from human pluripotent stem cells.
Lee G; Chambers SM; Tomishima MJ; Studer L
Nat Protoc; 2010 Apr; 5(4):688-701. PubMed ID: 20360764
[TBL] [Abstract][Full Text] [Related]
35. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
36. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
37. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
[TBL] [Abstract][Full Text] [Related]
38. Xeno-free culture and proliferation of hPSCs on 2D biomaterials.
Wang T; Yu T; Tsai CY; Hong ZY; Chao WH; Su YS; Subbiah SK; Renuka RR; Hsu ST; Wu GJ; Higuchi A
Prog Mol Biol Transl Sci; 2023; 199():63-107. PubMed ID: 37678982
[TBL] [Abstract][Full Text] [Related]
39. Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures.
Lam AT; Li J; Chen AK; Reuveny S; Oh SK; Birch WR
Stem Cells Dev; 2014 Jul; 23(14):1688-703. PubMed ID: 24641164
[TBL] [Abstract][Full Text] [Related]
40. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.
Abbasalizadeh S; Larijani MR; Samadian A; Baharvand H
Tissue Eng Part C Methods; 2012 Nov; 18(11):831-51. PubMed ID: 22559864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
